You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -249.0% | -104.5% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -4.8 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 10.4 | 5.2 |
Price / Book value | 1.0 |
Latest | Forecast | |
---|---|---|
Revenue | -5.9% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 2.77 | -0.53 | -0.16p | -78.1 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 2.05 | -1.48 | -0.55p | -16.4 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 1.37 | -2.55 | -0.66p | -17.4 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 1.29 | -3.40 | -0.73p | -10.4 | 0.0 | n/a | n/a | 0.0% |
Eden Research set to beat expectations for revenue, losses Sharecast News | 10 Jan |
---|---|
Eden Research inks distribution deal with Corteva France Sharecast News | 15 Dec |
Eden Research first-half loss set to narrow to £1.3m Sharecast News | 22 Aug |
US State Regulatory Approvals Update | 23-Mar-23 14:38 |
---|---|
First Mevalone authorisation for domestic use | 30-Jan-23 14:19 |
Trading Update | 10-Jan-23 14:16 |